Skip to main content
Watch Insiders

Corporate insider profile

Adam Crystal Insider Trades

Latest reported as President, R&D of Tango Therapeutics, Inc. (TNGX).

Purchase filings
0
Reported companies
1
Net open-market value
-$4,951,298.10
Latest transaction
Oct 1, 2026

Affiliated corporations

Reported company relationships

TNGXLatest reported

Tango Therapeutics, Inc.

President, R&D

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 1, 2026Tango Therapeutics, Inc. (TNGX)President, R&DSale27,000$24.47$660,795
Sep 1, 2026Tango Therapeutics, Inc. (TNGX)President, R&DSale27,000$22.37$603,909
Aug 3, 2026Tango Therapeutics, Inc. (TNGX)President, R&DSale27,000$27.24$735,518
Jul 1, 2026Tango Therapeutics, Inc. (TNGX)President, R&DSale27,000$29.59$798,908
Jun 1, 2026Tango Therapeutics, Inc. (TNGX)President, R&DSale27,000$22.87$617,571
May 1, 2026Tango Therapeutics, Inc. (TNGX)President, R&DSale27,000$21.23$573,097
Apr 15, 2026Tango Therapeutics, Inc. (TNGX)President, R&DSale38,460$25.00$961,500